Literature DB >> 29146722

The NOTCH4-HEY1 Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.

Takahito Fukusumi1, Theresa W Guo2, Akihiro Sakai1, Mizuo Ando1, Shuling Ren1, Sunny Haft1, Chao Liu1, Panomwat Amornphimoltham1, J Silvio Gutkind1, Joseph A Califano3.   

Abstract

Purpose: Recently, several comprehensive genomic analyses demonstrated NOTCH1 and NOTCH3 mutations in head and neck squamous cell carcinoma (HNSCC) in approximately 20% of cases. Similar to other types of cancers, these studies also indicate that the NOTCH pathway is closely related to HNSCC progression. However, the role of NOTCH4 in HNSCC is less well understood.Experimental Design: We analyzed NOTCH4 pathway and downstream gene expression in the TCGA data set. To explore the functional role of NOTCH4, we performed in vitro proliferation, cisplatin viability, apoptosis, and cell-cycle assays. We also compared the relationships among NOTCH4, HEY1, and epithelial-mesenchymal transition (EMT)-related genes using the TCGA data set and in vitro assays.
Results: HEY1 is specifically upregulated in HNSCC compared with normal tissues in the TCGA data set. NOTCH4 is more significantly related to HEY1 activation in HNSCC in comparison with other NOTCH receptors. NOTCH4 promotes cell proliferation, cisplatin resistance, inhibition of apoptosis, and cell-cycle dysregulation. Furthermore, NOTCH4 and HEY1 upregulation resulted in decreased E-cadherin expression and increased Vimentin, Fibronectin, TWIST1, and SOX2 expression. NOTCH4 and HEY1 expression was associated with an EMT phenotype as well as increased invasion and cell migration.Conclusions: In HNSCC, the NOTCH4-HEY1 pathway is specifically upregulated, induces proliferation and cisplatin resistance, and promotes EMT. Clin Cancer Res; 24(3); 619-33. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29146722      PMCID: PMC6171749          DOI: 10.1158/1078-0432.CCR-17-1366

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  73 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation.

Authors:  Luis Luna-Zurita; Belén Prados; Joaquim Grego-Bessa; Guillermo Luxán; Gonzalo del Monte; Alberto Benguría; Ralf H Adams; José María Pérez-Pomares; José Luis de la Pompa
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

3.  Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2.

Authors:  Hiroki Kokubo; Sachiko Tomita-Miyagawa; Yoshio Hamada; Yumiko Saga
Journal:  Development       Date:  2007-02       Impact factor: 6.868

4.  Jagged 1 regulates the restriction of Sox2 expression in the developing chicken inner ear: a mechanism for sensory organ specification.

Authors:  Joana Neves; Carolina Parada; Mireia Chamizo; Fernando Giráldez
Journal:  Development       Date:  2011-02       Impact factor: 6.868

5.  Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition.

Authors:  Andreas Fischer; Christian Steidl; Toni U Wagner; Esra Lang; Peter M Jakob; Peter Friedl; Klaus-Peter Knobeloch; Manfred Gessler
Journal:  Circ Res       Date:  2007-02-15       Impact factor: 17.367

6.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

Authors:  Yu-Chih Chen; Yi-Wei Chen; Han-Shui Hsu; Ling-Ming Tseng; Pin-I Huang; Kai-Hsi Lu; Dow-Tien Chen; Lung-Kuo Tai; Ming-Chi Yung; Shih-Ching Chang; Hung-Hai Ku; Shih-Hwa Chiou; Wen-Liang Lo
Journal:  Biochem Biophys Res Commun       Date:  2009-05-18       Impact factor: 3.575

7.  Pathway Analysis using Gene-expression Profiles of HPV-positive and HPV-negative Oropharyngeal Cancer Patients in a Hispanic Population: Methodological Procedures.

Authors:  Erick Suárez; Lorena González; Carlos Pérez-Mitchell; Ana P Ortiz; Maricarmen Ramírez-Sola; Jaime Acosta; Raúl D Bernabe-Dones; Carlos González-Aquino; Ingrid Montes-Rodríguez; Carmen L Cadilla
Journal:  P R Health Sci J       Date:  2016-03       Impact factor: 0.705

8.  A phase II study of RO4929097 in metastatic colorectal cancer.

Authors:  Jonathan R Strosberg; Timothy Yeatman; Jill Weber; Domenico Coppola; Michael J Schell; Gang Han; Khaldoun Almhanna; Richard Kim; Tiffany Valone; Helen Jump; Dan Sullivan
Journal:  Eur J Cancer       Date:  2012-03-23       Impact factor: 9.162

9.  Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression.

Authors:  A Tsuru; T Setoguchi; Y Matsunoshita; H Nagao-Kitamoto; S Nagano; M Yokouchi; S Maeda; Y Ishidou; T Yamamoto; S Komiya
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

10.  A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma.

Authors:  Ana De Jesus-Acosta; Daniel Laheru; Anirban Maitra; John Arcaroli; Michelle A Rudek; Arvind Dasari; Patrick J Blatchford; Kevin Quackenbush; Wells Messersmith
Journal:  Invest New Drugs       Date:  2014-03-27       Impact factor: 3.850

View more
  24 in total

Review 1.  Notch Signaling and Human Papillomavirus-Associated Oral Tumorigenesis.

Authors:  Trinath Das; Rong Zhong; Michael T Spiotto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Transcription Factor HEY1 Improves Brain Vascular Endothelial Cell Function and Alleviates Ischemic Stroke by Upregulating NOTCH3.

Authors:  Tingting Zhu; Hongxi Chen; Cuihong He; Xiaojuan Liu
Journal:  Neurochem Res       Date:  2022-03-22       Impact factor: 3.996

Review 3.  Roles of Notch Signaling in the Tumor Microenvironment.

Authors:  Antonino B D'Assoro; Roberto Leon-Ferre; Eike-Benjamin Braune; Urban Lendahl
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

Review 4.  Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas.

Authors:  Joanna Kałafut; Arkadiusz Czerwonka; Alinda Anameriç; Alicja Przybyszewska-Podstawka; Julia O Misiorek; Adolfo Rivero-Müller; Matthias Nees
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

5.  NOTCH4 Is a Novel Prognostic Marker that Correlates with Colorectal Cancer Progression and Prognosis.

Authors:  Guiyang Wu; Zaiping Chen; Jing Li; Fubo Ye; Guoping Chen; Qinghao Fan; Hao Dong; Shichao Yuan; Xiongwen Zhu
Journal:  J Cancer       Date:  2018-06-12       Impact factor: 4.207

6.  Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes.

Authors:  Yajun Chen; Feng Yang; Erhu Fang; Wenjing Xiao; Hong Mei; Huanhuan Li; Dan Li; Huajie Song; Jianqun Wang; Mei Hong; Xiaojing Wang; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

Review 7.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

8.  Comprehensive molecular profiling of pulmonary pleomorphic carcinoma.

Authors:  Masaaki Nagano; Shinji Kohsaka; Takuo Hayashi; Toshihide Ueno; Shinya Kojima; Aya Shinozaki-Ushiku; Shigeki Morita; Masumi Tsuda; Shinya Tanaka; Toshiya Shinohara; Yuko Omori; Fumiko Sugaya; Hiroaki Kato; Yoshiaki Narita; Jun Nakajima; Kenji Suzuki; Kazuya Takamochi; Hiroyuki Mano
Journal:  NPJ Precis Oncol       Date:  2021-06-22

9.  Numb has distinct function in lung adenocarcinoma and squamous cell carcinoma.

Authors:  Hajime Kikuchi; Jun Sakakibara-Konishi; Megumi Furuta; Eiki Kikuchi; Junko Kikuchi; Satoshi Oizumi; Yasuhiro Hida; Kichizo Kaga; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Masaharu Nishimura
Journal:  Oncotarget       Date:  2018-06-29

10.  Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.

Authors:  Matteo Dugo; Andrea Devecchi; Loris De Cecco; Erika Cecchin; Delia Mezzanzanica; Marialuisa Sensi; Marina Bagnoli
Journal:  Genes (Basel)       Date:  2019-09-05       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.